Viewing nowCombinationSimvastatin/Ezetimibe Tablet 10/20 mg
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201600869 · Approved 2016.02.16 · Insurance code 645905990
Improvement of hypercholesterolemia (primary·homozygous familial) and mixed hyperlipidemia
This medicine is used in patients with primary hypercholesterolemia and mixed hyperlipidemia, in combination with dietary modifications, to lower total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, and to raise HDL cholesterol. It can particularly be administered to patients with homozygous familial hypercholesterolemia either in conjunction with other lipid-lowering treatments or as an alternative. After appropriate risk factor assessment, this medicine may also be used for patients at high risk of atherogenic vascular diseases due to hypercholesterolemia. Furthermore, lipid-regulating agents should be used when there is a sufficient response to an intensified dietary regimen and non-pharmacological treatments. Before taking this medicine, the causes of secondary dyslipidemia must be identified. This medicine helps to improve cholesterol and lipid levels, reducing the risk of cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate or severe hepatic impairment (see Precautions, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [GFR] ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated GFR < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see Precautions, 5. General Precautions). Use in older adults No dose adjustment is necessary in older adults. Concomitant use with other medications (See Precautions, 6. Interactions.) Administer this medication at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients taking this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medication. Patients taking this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medication.
This medicine may cause muscle-related diseases, including myopathy or rhabdomyolysis. The risk of this occurring may be increased when taking high doses of this medicine or in combination with certain other medications. Therefore, if symptoms such as muscle pain, muscle weakness, or unexplained muscle symptoms occur, it is essential to consult a doctor immediately. This medicine is not administered to patients allergic to the components or those with active liver diseases, nor to pregnant or breastfeeding women. During pregnancy, the synthesis of cholesterol necessary for normal fetal development may be inhibited, posing a risk; therefore, use should be avoided. Additionally, this medicine should not be combined with certain potent liver enzyme inhibitors, fibrate medications, some antibiotics, and antiviral drugs due to the risk of severe side effects. Elderly patients or those with impaired liver function or severe myasthenia gravis should use this medicine cautiously and may require regular monitoring. During the use of this medicine, regular liver function tests and muscle-related tests should be conducted, and any abnormal symptoms should be reported to a healthcare professional immediately. Women who may become pregnant should avoid pregnancy while taking this medication and must stop it immediately upon confirmation of pregnancy. Breastfeeding women are also advised to discontinue breastfeeding while taking this medicine for safety. For children and adolescents, caution is required as the safety and efficacy of this medicine have not been thoroughly studied. When starting new medications while taking this medicine, it is crucial to inform healthcare providers about its use, and it is advisable to avoid certain foods such as grapefruit juice. In case of overdose, there is no specific antidote; treatment will be symptomatic based on the symptoms. To use this medicine safely, it is necessary to strictly follow the doctor's instructions and consult a specialist immediately if any unusual symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to air and moisture; therefore, the bottle must be tightly closed for storage. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.
White to off-white, double convex elongated tablets
30 tablets [(10 tablets/PTP) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.